Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kidney Early Evaluation Program (KEEP). Findings from a community screening program.

Janet B McGill1, Wendy Weinstock Brown2, Shu-Cheng Chen3

  • 1Division of Endocrinology, Metabolism, and Lipid Research, Washington University, St. Louis, MO, USA

The Diabetes Educator
|April 21, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Diabetes, obesity & metabolism·2026
Same author

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Diabetes care·2026
Same author

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Early Hemodynamic Safety of Simultaneous Initiation of Finerenone and Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes: The CONFIDENCE Trial.

Journal of the American College of Cardiology·2026
Same author

Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.

Journal of the American Society of Nephrology : JASN·2026
Same author

Sexual Dimorphism and Age Effects in CKD and Type 2 Diabetes in the CONFIDENCE Trial.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same journal

Correction to 'Competencies for Diabetes Care and Education Specialists' by Ryan et al. <i>The Diabetes Educator</i> 46(4), pages 384-397 (August 2020).

The Diabetes educator·2020
Same journal

<i>The Diabetes Educator</i> (<i>TDE</i>): Successes, Opportunities, and Future Changes.

The Diabetes educator·2020
Same journal

An Umbrella Review of Text Message Programs for Adults With Type 2 Diabetes.

The Diabetes educator·2020
Same journal

Community-Based Participatory Research Interventions to Improve Diabetes Outcomes: A Systematic Review.

The Diabetes educator·2020
Same journal

"Together We Can Return to Balance"-Eastern Woodlands Native Perspectives and Type 2 Diabetes: A Qualitative Study.

The Diabetes educator·2020
Same journal

The Healthy Eating and Living Against Noncommunicable Diseases Study: An Innovative Family-Based Intervention.

The Diabetes educator·2020
See all related articles
This summary is machine-generated.

The Kidney Early Evaluation Program (KEEP) screened high-risk individuals for chronic kidney disease (CKD). Community screenings identified a high prevalence of CKD, emphasizing the need for early detection and management.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) poses a significant global health burden.
  • Early identification of individuals at risk for CKD is crucial for timely intervention.
  • Existing screening programs may not adequately reach high-risk populations.

Purpose of the Study:

  • To evaluate the effectiveness of the Kidney Early Evaluation Program (KEEP) in identifying individuals at risk for CKD.
  • To encourage high-risk individuals to seek medical evaluation and management for kidney disease.
  • To establish a de-identified database for analyzing demographic and clinical data of screened participants.

Main Methods:

  • Community-based screening utilizing a standardized questionnaire and test panel.

Related Experiment Videos

  • Targeting individuals with a personal history of diabetes, hypertension, or a family history of kidney disease.
  • Data collection and management by the KEEP Data Coordinating Center.

    • Main Results:

    • Analysis of data from 11,246 participants revealed a population enriched with African Americans and older individuals.
    • Diabetes was present in 2690 participants (self-report or abnormal blood glucose).
    • CKD was identified in 47.4% of the screened high-risk population.

    Conclusions:

    • Targeted community screening effectively identifies a substantial number of individuals with CKD.
    • Such programs can raise awareness about kidney disease.
    • Screening may promote improved health-seeking behaviors among at-risk individuals.